匯控(00005.HK)倫敦股價升1.3% 較港股收市低1.5%
匯控(00005.HK)倫敦股價昨日(1日)升1.3%,報654.9便士,折合65.33港元,較昨日港股收市價66.3港元低1.5%。該股低見649.9便士,折合64.83港元。
匯控昨日中午收市後公布中期業績,列賬基準除稅前利潤按年升1.47倍至216.57億美元,高於本網綜合4間券商預測上限的211.89億美元;列賬基準除稅後利潤按年升1.02倍至180.71億美元;每股盈利0.86美元。二次股息每股10美仙,符合預期。另計劃進一步回購最多達20億美元股份,預期回購將於短期展開,並於三個月內完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.